Bentham Science Logo

Current Signal Transduction Therapy

Volume 14, 2 Issues, 2019
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 6 - Number 2









HGF-Antagonists: Structure, Activities, and Anti-cancer Approach

, 6(2): 191 - 199

Katsuya Sakai, Takahiro Nakamura, Takayoshi Kinoshita, Toshikazu Nakamura and Kunio Matsumoto


DOI: 10.2174/157436211795659964




HGF as Angiogenic Factor and Therapeutic Approach

, 6(2): 221 - 227

Yoshiaki Taniyama, Yasushi Takeya, Junya Azuma, Kazuma Iekushi, Fumihiro Sanada, Hiroshi Kusunoki, Keita Okayama, Nobutaka Koibuchi, Hiromi Rakugi and Ryuichi Morishita


DOI: 10.2174/157436211795660016


HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

, 6(2): 228 - 233

Seiji Yano, Wei Wang, Qi Li, Tadaaki Yamada, Shinji Takeuchi, Kunio Matsumoto, Yasuhiko Nishioka and Saburo Sone


DOI: 10.2174/157436211795659928










Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
USA

Biography View Full Editorial Board

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog